Clinical trials demonstrate that maximal therapeutic effects generally require several months of treatment at the target maintenance dose, which is typically reached through a gradual dose escalation process
When I look at how these patches are marketed, I can see why people are drawn in
Repurposing GLP-1 receptor agonists and novel dual/triple GLP-1, GIP, and glucagon agonists represent promising therapeutic strategies that have shown to be effective in targeting inflammation, tau phosphorylation, synaptic dysfunction, insulin resistance, and oxidative stress
Because of these risks, informed consent is critical
Requires bacteriostatic water to reconstitute, sold separately
I read the clinical trial data